Jaguar Health to Present September 19 at the MedInvest Biotech & Pharma Investor Conference
Jaguar Health (NASDAQ:JAGX) has announced that its founder, president, and CEO, Lisa Conte, will present at the MedInvest Biotech & Pharma Investor Conference on September 19, 2024, in New York City. The presentation is scheduled for 9:55 AM to 10:10 AM Eastern time. Conte will also participate in one-on-one meetings during the event, which runs from September 18-19.
This conference provides Jaguar Health with an opportunity to showcase its developments and connect with potential investors in the biotech and pharmaceutical sectors. Interested parties can register for the presentation through a provided link, allowing them to gain insights into Jaguar Health's current projects and future prospects.
Jaguar Health (NASDAQ:JAGX) ha annunciato che il suo fondatore, presidente e CEO, Lisa Conte, presenterà alla MedInvest Biotech & Pharma Investor Conference il 19 settembre 2024, a New York City. La presentazione è programmata per le 9:55 AM fino alle 10:10 AM ora orientale. Conte parteciperà anche a incontri individuali durante l'evento, che si svolgerà dal 18 al 19 settembre.
Questa conferenza offre a Jaguar Health l'opportunità di mostrare i propri sviluppi e di connettersi con potenziali investitori nei settori biotech e farmaceutico. Le parti interessate possono registrarsi per la presentazione tramite un link fornito, permettendo loro di ottenere informazioni sui progetti attuali e sulle prospettive future di Jaguar Health.
Jaguar Health (NASDAQ:JAGX) ha anunciado que su fundador, presidente y CEO, Lisa Conte, presentará en la MedInvest Biotech & Pharma Investor Conference el 19 de septiembre de 2024, en la ciudad de Nueva York. La presentación está programada de 9:55 AM a 10:10 AM, hora del Este. Conte también participará en reuniones uno a uno durante el evento, que se lleva a cabo del 18 al 19 de septiembre.
Esta conferencia ofrece a Jaguar Health la oportunidad de mostrar sus desarrollos y conectar con inversionistas potenciales en los sectores biotecnológico y farmacéutico. Las partes interesadas pueden registrarse para la presentación a través de un enlace proporcionado, lo que les permite obtener información sobre los proyectos actuales y las perspectivas futuras de Jaguar Health.
재규어 헬스 (NASDAQ:JAGX)는 창립자이자 회장, CEO인 리사 콘트가 2024년 9월 19일 뉴욕시에서 열리는 메드인베스트 바이오텍 & 제약 투자자 회의에서 발표할 것이라고 발표했습니다. 발표는 동부 표준시로 오전 9시 55분부터 10시 10분까지 예정되어 있습니다. 콘트는 9월 18일부터 19일까지 열리는 행사 기간 동안 1 대 1 회의에도 참여할 예정입니다.
이번 회의는 재규어 헬스에게 자사의 개발을 선보이고 바이오텍 및 제약 분야의 잠재 투자자와 연결할 수 있는 기회를 제공합니다. 관심 있는 분들은 제공된 링크를 통해 발표에 등록할 수 있으며, 이를 통해 재규어 헬스의 현재 프로젝트와 향후 전망에 대한 통찰을 얻을 수 있습니다.
Jaguar Health (NASDAQ:JAGX) a annoncé que sa fondatrice, présidente et CEO, Lisa Conte, présentera lors de la MedInvest Biotech & Pharma Investor Conference le 19 septembre 2024, à New York. La présentation est prévue de 9h55 à 10h10, heure de l'Est. Conte participera également à des réunions individuelles pendant l'événement, qui se déroule du 18 au 19 septembre.
Cette conférence offre à Jaguar Health l'opportunité de mettre en avant ses développements et de se connecter avec de potentiels investisseurs dans les secteurs de la biotechnologie et de la pharmacie. Les parties intéressées peuvent s'inscrire à la présentation via un lien fourni, leur permettant d'obtenir des informations sur les projets actuels et les perspectives futures de Jaguar Health.
Jaguar Health (NASDAQ:JAGX) hat bekannt gegeben, dass die Gründerin, Präsidentin und CEO, Lisa Conte, am 19. September 2024 auf der MedInvest Biotech & Pharma Investor Conference in New York City präsentieren wird. Die Präsentation ist von 9:55 bis 10:10 Uhr Eastern Time angesetzt. Conte wird auch an Einzelgesprächen während der Veranstaltung, die vom 18. bis 19. September stattfindet, teilnehmen.
Diese Konferenz bietet Jaguar Health die Möglichkeit, ihre Entwicklungen zu präsentieren und mit potenziellen Investoren im Biotech- und Pharmasektor in Kontakt zu treten. Interessierte Parteien können sich über einen bereitgestellten Link zur Präsentation anmelden, um Einblicke in die aktuellen Projekte und zukünftigen Perspektiven von Jaguar Health zu erhalten.
- None.
- None.
SAN FRANCISCO, CA / ACCESSWIRE / September 16, 2024 / Jaguar Health, Inc.(NASDAQ:JAGX) today announced that Lisa Conte, the company's founder, president and CEO, will present in person on September 19, 2024 at the MedInvest Biotech & Pharma Investor Conference and participate in one-on-one meetings at the event, which is taking place September 18-19 in New York City.
Participation Instructions for Jaguar Health's Presentation at the MedInvest Biotech & Pharma Investor Conference
When: Thursday, September 19, 2024 from 9:55 AM Eastern to 10:10 AM Eastern
Registration link for presentation: Click Here
About the Jaguar Health Family of Companies
Jaguar Health, Inc. (Jaguar) is a commercial stage pharmaceuticals company focused on developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for people and animals with gastrointestinal distress, specifically associated with overactive bowel, which includes symptoms such as chronic debilitating diarrhea, urgency, bowel incontinence, and cramping pain. Jaguar family company Napo Pharmaceuticals (Napo) focuses on developing and commercializing human prescription pharmaceuticals for essential supportive care and management of neglected gastrointestinal symptoms across multiple complicated disease states. Napo's crofelemer is FDA-approved under the brand name Mytesi® for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. Jaguar family company Napo Therapeutics is an Italian corporation Jaguar established in Milan, Italy in 2021 focused on expanding crofelemer access in Europe and specifically for orphan and/or rare diseases. Jaguar Animal Health is a Jaguar tradename. Magdalena Biosciences, a joint venture formed by Jaguar and Filament Health Corp. that emerged from Jaguar's Entheogen Therapeutics Initiative (ETI), is focused on developing novel prescription medicines derived from plants for mental health indications.
For more information about:
Jaguar Health, visit https://jaguar.health
Napo Pharmaceuticals, visit www.napopharma.com
Napo Therapeutics, visit napotherapeutics.com
Magdalena Biosciences, visit magdalenabiosciences.com
Visit the Make Cancer Less Shitty patient advocacy program at makecancerlessshitty.com and on X, Facebook & Instagram
Forward-Looking Statements
Certain statements in this press release constitute "forward-looking statements." These include statements regarding Jaguar's expectation that Jaguar management will present at the MedInvest Biotech & Pharma Investor Conference. In some cases, you can identify forward-looking statements by terms such as "may," "will," "should," "expect," "plan," "aim," "anticipate," "could," "intend," "target," "project," "contemplate," "believe," "estimate," "predict," "potential" or "continue" or the negative of these terms or other similar expressions. The forward-looking statements in this release are only predictions. Jaguar has based these forward-looking statements largely on its current expectations and projections about future events. These forward-looking statements speak only as of the date of this release and are subject to several risks, uncertainties, and assumptions, some of which cannot be predicted or quantified and some of which are beyond Jaguar's control. Except as required by applicable law, Jaguar does not plan to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise.
Contact:
hello@jaguar.health
Jaguar-JAGX
SOURCE: Jaguar Health, Inc.
View the original press release on accesswire.com
FAQ
When is Jaguar Health (JAGX) presenting at the MedInvest Biotech & Pharma Investor Conference?
Who will be representing Jaguar Health (JAGX) at the MedInvest conference?
What activities will Jaguar Health (JAGX) participate in at the MedInvest conference?
How long is the MedInvest Biotech & Pharma Investor Conference where Jaguar Health (JAGX) is presenting?
Can investors attend Jaguar Health's (JAGX) presentation at the MedInvest conference?
